Literature DB >> 1470301

The comparison of benzodiazepine derivatives and serotonergic agonists and antagonists in two animal models of anxiety.

R Stefański1, W Pałejko, W Kostowski, A Płaźnik.   

Abstract

The present paper compares the effects of different serotonergic agonists and antagonists with benzodiazepine derivatives in two animal models of anxiety; the Vogel's and the open-field tests. In the Vogel's conflict test, both diazepam and midazolam produced an anti-punishment action. The drugs 8-OH-DPAT (0.025 and 0.05 mg/kg), buspirone (0.62 mg/kg), gepirone and ipsapirone (0.3 and 0.62 mg/kg, respectively) increased punished intake of water. Ritanserin disinhibited the behaviour of rats at the doses of 2.5 and 5.0 mg/kg and ICS 205-930 (0.001 and 0.01 mg/kg) exerted a marked increase in punished drinking, while ondansetron was active only after the largest dose (1.5 mg/kg). In the open-field test, all drugs increased the number of entries into the central area, as well as the time spent in the central sector of the open-field. The present data indicate similar but not identical spectra of pharmacological sensitivity of both ethologically-oriented and conflict tests, for various classes of anxiolytic drugs. The 5-HT1A receptor agonists and 5-HT2 receptor antagonist have been shown to have similar anxiolytic-like profile to the benzodiazepines but in a narrower dose-range. The 5-HT3 receptor antagonists appeared to be unique in respect to their very strong anti-emotional activity (ICS 205-930), devoid of any clear-cut general inhibitory properties upon locomotion.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1470301     DOI: 10.1016/0028-3908(92)90053-r

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  11 in total

1.  Midazolam inhibits neophobia-induced Fos expression in the rat hippocampus.

Authors:  A Wisłowska-Stanek; M Zienowicz; M Lehner; E Taracha; A Bidziński; P Maciejak; A Skórzewska; J Szyndler; A Płaźnik
Journal:  J Neural Transm (Vienna)       Date:  2006-01       Impact factor: 3.575

Review 2.  Therapeutic role of 5-HT1A receptors in the treatment of schizophrenia and Parkinson's disease.

Authors:  Yukihiro Ohno
Journal:  CNS Neurosci Ther       Date:  2010-11-21       Impact factor: 5.243

3.  Benzodiazepine-GABAA receptor complex ligands in two models of anxiety.

Authors:  M Nazar; M Jessa; A Płaźnik
Journal:  J Neural Transm (Vienna)       Date:  1997       Impact factor: 3.575

4.  Overcrowding induces anxiety and causes loss of serotonin 5HT-1a receptors in rats.

Authors:  W M Daniels; C Y Pietersen; M E Carstens; S Daya; D Stein
Journal:  Metab Brain Dis       Date:  2000-12       Impact factor: 3.584

Review 5.  The age of anxiety: role of animal models of anxiolytic action in drug discovery.

Authors:  John F Cryan; Fabian F Sweeney
Journal:  Br J Pharmacol       Date:  2011-10       Impact factor: 8.739

Review 6.  Ondansetron. A review of its pharmacology and preliminary clinical findings in novel applications.

Authors:  M I Wilde; A Markham
Journal:  Drugs       Date:  1996-11       Impact factor: 9.546

7.  Improving the Treatment of Parkinson's Disease: A Novel Approach by Modulating 5-HT(1A) Receptors.

Authors:  Saki Shimizu; Yukihiro Ohno
Journal:  Aging Dis       Date:  2012-11-29       Impact factor: 6.745

8.  Evidence that 5-HT2c receptor antagonists are anxiolytic in the rat Geller-Seifter model of anxiety.

Authors:  G A Kennett; K Pittaway; T P Blackburn
Journal:  Psychopharmacology (Berl)       Date:  1994-02       Impact factor: 4.530

9.  Novelty and anxiolytic drugs dissociate two components of hippocampal theta in behaving rats.

Authors:  Christine E Wells; Doran P Amos; Ali Jeewajee; Vincent Douchamps; John Rodgers; John O'Keefe; Neil Burgess; Colin Lever
Journal:  J Neurosci       Date:  2013-05-15       Impact factor: 6.167

10.  Role of Hypothalamic-pituitary-adrenal-axis in Affective Disorders: Anti-depressant and Anxiolytic Activity of Partial 5-HT1A Agonist in Adrenalectomised Rats.

Authors:  Deepali Gupta; Mahesh Radhakrishnan; Shvetank Bhatt; Yeshwant Kurhe
Journal:  Indian J Psychol Med       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.